Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.483NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.181ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.181ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.181ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.181NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.113ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.113ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.113ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.113NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.594ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.594ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.594ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.594NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.328ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.328ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.328ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.328NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.145ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.145ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.145ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.145NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.547ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.547ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.547ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.547NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.247ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.247ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.247ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.247NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.4.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.4.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.4.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.4.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.205ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.205ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.205ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.205NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.110ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.110ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.110ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.110NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.434ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.434ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.434ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.434NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.4.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used